Source / episode info

• **Episode:**215
• **Title:**Divine Intervention Episode 215 – Acetylcholine and The NBME.
• **Published:**2020-02-28
• Source:Episode page

One-liner

This episode provides a comprehensive review of acetylcholine physiology, covering the action potential generation in neurons, the mechanism of neuromuscular transmission (nAChR/T-tubule coupling), and high-yield pathologies including Myasthenia Gravis, Lambert-Eaton Syndrome, Botulism, Tetanus, and Malignant Hyperthermia.

High-yield summary

• Neuromuscular Junction: Acetylcholine (ACh) acts on the postsynaptic nicotinic acetylcholine receptor (nAChR), which is a ligand-gated ion channel. Depolarization of the muscle fiber spreads via T-tubules, triggering Ca2+ release from the sarcoplasmic reticulum (SR) via the Dihydropyridine Receptor/Ryanodine Receptor coupling.
• Myasthenia Gravis (MG): Autoantibodies target the postsynaptic nAChR. Symptoms worsen with effort and are treated by AChE inhibitors (Pyridostigmine) to increase synaptic ACh concentration, allowing outcompetition of antibodies.
• Lambert-Eaton Myasthenic Syndrome (LEMS): Autoantibodies target the presynaptic voltage-gated Ca2+ channels. This impairs ACh release; symptoms improve with repeated muscle use due to increased calcium influx, resulting in an incremental response. Associated with small cell lung cancer.
• Toxins vs. Antibodies: Botulism toxin cleaves SNARE proteins, preventing ACh vesicle release (flaccid paralysis). Tetanus toxin blocks inhibitory neurotransmitters (GABA/Glycine) in Renshaw cells, causing spastic paralysis.
• Pharmacology & Toxins: Organophosphate poisoning causes a cholinergic crisis by inhibiting AChE. Treatment is sequential: first Atropine (antagonist), then Pralidoxime (regenerator). Neuromuscular blocking agents are classified as depolarizing (Succinylcholine) or non-depolarizing (Rocuronium, etc.).
• Malignant Hyperthermia (MH): Caused by a mutation in the RyR receptor. The mutant channel remains leaky/open, causing uncontrolled calcium release and massive muscle contraction, leading to hypercalcemia and rhabdomyolysis. Treatment is Dantrolene.

Learning objectives

• Differentiate the pathophysiology and clinical presentation of Myasthenia Gravis vs. Lambert-Eaton Syndrome.
• Describe the mechanism of action for various toxins (Botulism, Tetanus) and their resulting paralysis patterns.
• Outline the sequential management steps for cholinergic crisis due to organophosphate poisoning.
• Identify the specific receptor mutation responsible for Malignant Hyperthermia and its targeted antidote.
• Classify neuromuscular blocking agents based on mechanism of action (depolarizing vs. non-depolarizing) and reversal agents.